Yuki Hirase, Takaaki Arigami, Yota Kawasaki, Daisuke Matsushita, Masataka Shimonosono, Yusuke Tsuruda, Ken Sasaki, Yoichi Yamasaki, Takahiko Hagihara, Hidetoshi Noma, Michiyo Higashi, Hiroshi Kurahara, Takao Ohtsuka
BACKGROUND: Conversion surgery (CS) after chemotherapy is weakly recommended as a promising tool for improving prognoses in patients with unresectable gastric cancer. Moreover, several investigators have demonstrated the clinical efficacy of subtotal gastrectomy (sTG) with a small remnant stomach for the nutritional status and surgical outcome compared with total gastrectomy. Here, we report a patient with liver metastasis from human epidermal growth factor receptor 2 (HER2)-positive gastric cancer who underwent sTG and hepatectomy after trastuzumab-based chemotherapy...
March 5, 2024: Surgical Case Reports